Loading...

Thomas Hope, MD

Title(s)Associate Professor, Radiology
SchoolSchool of Medicine
Address185 Berry Street Bldg B
San Francisco CA 94158
Phone415-221-4810 ext. 22648
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Society of Nuclear Medicine and Molecular Imaging2020Hal O’Brien Rising Star Award Winner
    North American Neuroendocrine Tumor Society2018Theragnostics Investigator Award
    Prostate Cancer Foundation2017Young Investigator Award
    Society of Nuclear Medicine and Molecular Imaging2016Marc Tetalman Award
    Society of Nuclear Medicine and Molecular Imaging2016Henkin Fellowship
    Society of Abdominal Radiology2014Wylie J. Dodds Research Award
    University of California, San Francisco 2012Alexander Margulis Society Outstanding Research Award
    Radiological Society of North America2012Roentgen Resident/Fellow Research Award
    Radiological Society of North America2010Presidents Circle Research Resident Grant
    ISMRM2007W.S. Moore Award Nominee
    Radiological Society of North America2006Trainee Research Prize

    Collapse Overview 
    Collapse Overview
    Thomas Hope, MD, is the Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. He is also the Associate Chair for Joint Ventures for Radiology. He serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center. He also serves as chair of the Cancer Center’s Molecular Imaging & Radionuclide Therapy Site Committee. In 2007, he received his medical degree from Stanford University School of Medicine and he completed a one-year internship at Kaiser Permanente, San Francisco. From 2008-2012, Dr. Hope completed a residency in Diagnostic Radiology at the University of California, San Francisco, followed by a clinical fellowship in Body MRI and Nuclear Medicine from Stanford Medical Center in 2013.

    Dr. Hope’s main research focus is on novel imaging agents and therapies, particularly in prostate cancer and neuroendocrine tumors. He lead the development of Ga-68 PSMA-11, which subsequently led to the approval of this drug by the FDA. He has combined his interest in MR imaging with PET in the simultaneous modality PET/MRI, helping lead the development of the clinical PET/MRI program. Additionally he leads the PRRT (peptide receptor radionuclide therapy) program for neuroendocrine tumors at UCSF.

    An international leader in PET/MR research and the translation of new molecular imaging agents, Dr. Hope launched the highly successful PSMA prostate program at UCSF and championed the use of multiple new targeted therapies to treat patients with neuroendocrine and other tumors. He current serves as principal investigator on grants from the NIH, the Prostate Cancer Foundation. He is the recipient of numerous accolades in molecular imaging, including the Henkin Fellow and Marc Tetalman Memorial Award from the Society of Nuclear Medicine and Molecular Imaging, the Young Investigator Award from the Prostate Cancer Foundation and the Wylie J. Dodds Research Award from the Society of Abdominal Radiology.

    Expertise:
    Abdominal Imaging and Nuclear Medicine, and Molecular Imaging and Therapeutics

    Professional Interests:
    Novel imaging agents, PET/MR, prostate cancer, neuroendocrine tumor, targeted radiotherapy

    Education and Training:
    • Medical School: Stanford University School of Medicine, California
    • Internship: Kaiser Permanente, San Francisco, California
    • Residency: University of California, San Francisco - Diagnostic Radiology
    • Fellowship: Stanford Medical Center, California - Body MRI and Nuclear Medicine
    • California Medical License
    • American Board of Radiology, Certificate in Diagnostic Radiology
    • American Board of Nuclear Medicine, Certificate in Nuclear Medicine

    Collapse Research 
    Collapse Research Activities and Funding
    MELT: Modulation of PSMA Expression for Lutetium Therapy
    NIH R01CA235741Jul 1, 2019 - Jun 30, 2025
    Role: Principal Investigator
    Immunogenic Priming with Lu-PSMA Targeted Therapy in Advanced Prostate Cancer
    NIH R01CA229354Jun 1, 2019 - Apr 30, 2021
    Role: Co-Principal Investigator
    Qualification and Harmonization of PET/MRI for Cancer Clinical Trials
    NIH R01CA212148Mar 6, 2017 - Feb 28, 2022
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET. Eur J Nucl Med Mol Imaging. 2021 Feb 19. PMID: 33604691.
      View in: PubMed   Mentions:    Fields:    
    2. More Answers and More Questions About Radiotherapy for Metastatic Prostate Cancer. JAMA Oncol. 2021 Feb 18. PMID: 33599702.
      View in: PubMed   Mentions:    Fields:    
    3. PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer. Lancet. 2021 Feb 11. PMID: 33581799.
      View in: PubMed   Mentions:    Fields:    
    4. Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA. J Nucl Med. 2021 Feb; 62(2):146-148. Sartor O, Hope TA, Calais J, Fendler WP. PMID: 33468543.
      View in: PubMed   Mentions:    Fields:    
    5. The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer. Eur Urol Focus. 2021 Feb 01. Murthy V, Sonni I, Jariwala N, Juarez R, Reiter RE, Raman SS, Hope TA. PMID: 33541838.
      View in: PubMed   Mentions:    Fields:    
    6. Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta-analysis. J Nucl Med. 2021 Jan 15. Whitman J, Allen IE, Bergsland EK, Suh IA, Hope TA. PMID: 33452040.
      View in: PubMed   Mentions:    Fields:    
    7. Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome. Eur Urol Focus. 2020 Dec 29. Calais J, Armstrong WR, Kishan AU, Booker KM, Hope TA, Fendler WP, Elashoff D, Nickols NG, Czernin J. PMID: 33386288.
      View in: PubMed   Mentions:    Fields:    
    8. Effect of microdistribution of alpha and beta-emitters in targeted radionuclide therapies on delivered absorbed dose in a GATE model of bone marrow. Phys Med Biol. 2020 Dec 15. Tranel J, Feng FY, St James ST, Hope TA. PMID: 33321484.
      View in: PubMed   Mentions:    Fields:    
    9. Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET. J Nucl Med. 2020 Dec; 61(12):1764. Hope TA. PMID: 33262268.
      View in: PubMed   Mentions:    Fields:    
    10. From Compassionate Use to Phase 3 Trial: The Impact of Germany's PSMA-617 Literature. J Nucl Med. 2020 12; 61(Suppl 2):255S-256S. PMID: 33293446.
      View in: PubMed   Mentions:    Fields:    
    11. Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer. Cancer Med. 2020 Nov 28. Borno HT, Kuo Lin T, Odisho AY, Desai A, Koshkin V, Werner K, Legaspi N, Bucknor M, Bell A, Zhang S, Hope TA. PMID: 33247633.
      View in: PubMed   Mentions:    Fields:    
    12. Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study. EJNMMI Res. 2020 Oct 22; 10(1):128. Lawhn-Heath C, Yom SS, Liu C, Villanueva-Meyer JE, Aslam M, Smith R, Narwal M, Juarez R, Behr SC, Pampaloni MH, Chan JW, Glastonbury CM, Hope TA, Flavell RR. PMID: 33090273.
      View in: PubMed   Mentions:
    13. Introduction to the D-SPECT for Technologists: Workflow Using a Dedicated Digital Cardiac Camera. J Nucl Med Technol. 2020 Dec; 48(4):297-303. PMID: 33020236.
      View in: PubMed   Mentions:    Fields:    
    14. Disparities in PET imaging for prostate cancer at a tertiary academic medical center. J Nucl Med. 2020 Sep 25. Bucknor MD, Lichtensztajn DY, Lin TK, Borno HT, Gomez SL, Hope TA. PMID: 32978283.
      View in: PubMed   Mentions:    Fields:    
    15. A Conversation Between Joseph Osborne and Thomas Hope. J Nucl Med. 2020 Sep; 61(9):1275-1277. Osborne JR, Hope TA. PMID: 32873736.
      View in: PubMed   Mentions:    Fields:    
    16. NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer. Int J Radiat Oncol Biol Phys. 2021 Jan 01; 109(1):174-185. Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, Tree AC, Efstathiou JA, Harisinghani M, Jani AB, Buyyounouski MK, Pisansky TM, Tran PT, Karnes RJ, Chen RC, Cury FL, Michalski JM, Rosenthal SA, Koontz BF, Wong AC, Nguyen PL, Hope TA, Feng F, Sandler HM, Lawton CAF. PMID: 32861817.
      View in: PubMed   Mentions:    Fields:    
    17. 68Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality. EJNMMI Phys. 2020 Aug 26; 7(1):54. Murthy V, Smith RL, Tao DH, Lawhn-Heath CA, Korenchan DE, Larson PEZ, Flavell RR, Hope TA. PMID: 32844310.
      View in: PubMed   Mentions:
    18. False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial. Eur J Nucl Med Mol Imaging. 2020 Aug 17. Fendler WP, Calais J, Eiber M, Simko JP, Kurhanewicz J, Santos RD, Feng FY, Reiter RE, Rettig MB, Nickols NG, Kishan AU, Slavik R, Carroll PR, Lawhn-Heath C, Herrmann K, Czernin J, Hope TA. PMID: 32808077.
      View in: PubMed   Mentions:    Fields:    
    19. PET/Magnetic Resonance Imaging Applications in Abdomen and Pelvis. Magn Reson Imaging Clin N Am. 2020 Aug; 28(3):369-380. Panda A, Goenka AH, Hope TA, Veit-Haibach P. PMID: 32624155.
      View in: PubMed   Mentions:    Fields:    
    20. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors. Pancreas. 2020 08; 49(7):863-881. Halfdanarson TR, Strosberg JR, Tang L, Bellizzi AM, Bergsland EK, O'Dorisio TM, Halperin DM, Fishbein L, Eads J, Hope TA, Singh S, Salem R, Metz DC, Naraev BG, Reidy-Lagunes DL, Howe JR, Pommier RF, Menda Y, Chan JA. PMID: 32675783.
      View in: PubMed   Mentions:    Fields:    
    21. Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines. J Thorac Oncol. 2020 10; 15(10):1577-1598. Singh S, Bergsland EK, Card CM, Hope TA, Kunz PL, Laidley DT, Lawrence B, Leyden S, Metz DC, Michael M, Modahl LE, Myrehaug S, Padda SK, Pommier RF, Ramirez RA, Soulen M, Strosberg J, Sung A, Thawer A, Wei B, Xu B, Segelov E. PMID: 32663527.
      View in: PubMed   Mentions:    Fields:    
    22. North American Neuroendocrine Tumor Society Guide for Neuroendocrine Tumor Patient Health Care Providers During COVID-19. Pancreas. 2020 07; 49(6):723-728. Bergsland EK, Halperin DM, Dillon JS, Dasari NA, Kunz PL, Soares HP, Pryma D, Bodei L, Hope T, Soulen MC, Mailman J, Howe JR. PMID: 32433264.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    23. Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns? J Nucl Med. 2020 Aug; 61(8):1094-1095. Bodei L, Bergsland E, de Herder WW, Ferone D, Hicks RJ, Hope TA, Kunikowska J, Pavel M, Reidy-Lagunes D, Siveke J, Strosberg J, Dittmer U, Herrmann K. PMID: 32576637.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    24. Intra-arterial Peptide Receptor Radionuclide Therapy using 90Y DOTATOC for Hepatic Metastases of Neuroendocrine Tumors. J Nucl Med. 2020 Jun 08. Lawhn-Heath C, Fidelman N, Chee B, Jivan S, Armstrong E, Zhang L, Lindsay S, Bergsland EK, Hope TA. PMID: 32513903.
      View in: PubMed   Mentions:    Fields:    
    25. Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial. J Nucl Med. 2020 Dec; 61(12):1793-1799. Fendler WP, Ferdinandus J, Czernin J, Eiber M, Flavell RR, Behr SC, Wu IK, Lawhn-Heath C, Pampaloni MH, Reiter RE, Rettig MB, Gartmann J, Murthy V, Slavik R, Carroll PR, Herrmann K, Calais J, Hope TA. PMID: 32358094.
      View in: PubMed   Mentions: 2     Fields:    
    26. Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer. J Nucl Med. 2020 Dec; 61(12):1779-1785. Chiu LW, Lawhn-Heath C, Behr SC, Juarez R, Perez PM, Lobach I, Bucknor MD, Hope TA, Flavell RR. PMID: 32303599.
      View in: PubMed   Mentions: 1     Fields:    
    27. A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors. J Surg Oncol. 2020 Aug; 122(2):204-211. Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK. PMID: 32291778.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. A Conversation with John Sunderland, Johannes Czernin, and Thomas Hope. J Nucl Med. 2020 04; 61(4):477-479. Sunderland JJ, Czernin J, Hope T. PMID: 32238494.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment. J Nucl Med. 2020 04; 61(4):552-562. Jadvar H, Ballas LK, Choyke PL, Fanti S, Gulley JL, Herrmann K, Hope TA, Klitzke AK, Oldan JD, Pomper MG, Rowe SP, Subramaniam RM, Taneja SS, Vargas HA, Ahuja S. PMID: 32238495.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Bone material analogues for PET/MRI phantoms. Med Phys. 2020 Jun; 47(5):2161-2170. Chandramohan D, Cao P, Han M, An H, Sunderland JJ, Kinahan PE, Laforest R, Hope TA, Larson PEZ. PMID: 32034945.
      View in: PubMed   Mentions: 1     Fields:    
    31. NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy. J Nucl Med. 2020 02; 61(2):222-227. Hope TA, Bodei L, Chan JA, El-Haddad G, Fidelman N, Kunz PL, Mailman J, Menda Y, Metz DC, Mittra ES, Pryma DA, Reidy-Lagunes DL, Singh S, Strosberg JR. PMID: 32015164.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline. J Clin Oncol. 2020 Jun 10; 38(17):1963-1996. Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA. PMID: 31940221.
      View in: PubMed   Mentions: 3     Fields:    
    33. The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors. Pancreas. 2020 01; 49(1):1-33. Howe JR, Merchant NB, Conrad C, Keutgen XM, Hallet J, Drebin JA, Minter RM, Lairmore TC, Tseng JF, Zeh HJ, Libutti SK, Singh G, Lee JE, Hope TA, Kim MK, Menda Y, Halfdanarson TR, Chan JA, Pommier RF. PMID: 31856076.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    34. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis. J Surg Oncol. 2019 Dec 11. Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK. PMID: 31828813.
      View in: PubMed   Mentions:    Fields:    
    35. Mucinous rectal cancer: concepts and imaging challenges. Abdom Radiol (NY). 2019 11; 44(11):3569-3580. Horvat N, Hope TA, Pickhardt PJ, Petkovska I. PMID: 30993392.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply. Lancet Oncol. 2019 11; 20(11):e609-e610. Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Fendler WP, Czernin J. PMID: 31674314.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Rectal cancer lexicon: consensus statement from the society of abdominal radiology rectal & anal cancer disease-focused panel. Abdom Radiol (NY). 2019 11; 44(11):3508-3517. Hope TA, Gollub MJ, Arya S, Bates DDB, Ganeshan D, Harisinghani M, Jhaveri KS, Kassam Z, Kim DH, Korngold E, Lalwani N, Moreno CC, Nougaret S, Paroder V, Paspulati RM, Golia Pernicka JS, Petkovska I, Pickhardt PJ, Rauch GM, Rosenthal MH, Sheedy SP, Horvat N. PMID: 31388697.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. The use of PET/MRI for imaging rectal cancer. Abdom Radiol (NY). 2019 11; 44(11):3559-3568. Hope TA, Kassam Z, Loening A, McNamara MM, Paspulati R. PMID: 31201431.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Prognostic impact of a large mesenteric mass >2?cm in ileal neuroendocrine tumors. J Surg Oncol. 2019 Dec; 120(8):1311-1317. Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK. PMID: 31613999.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. A multi-disciplinary model of survivorship care following definitive chemoradiation for anal cancer. BMC Cancer. 2019 Sep 11; 19(1):906. Savoie MB, Laffan A, Brickman C, Daniels B, Levin A, Rowen T, Smith J, Van Blarigan EL, Hope TA, Berry-Lawhorn JM, Anwar M, Van Loon K. PMID: 31510960.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    41. Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2019 12 15; 25(24):7448-7454. Fendler WP, Weber M, Iravani A, Hofman MS, Calais J, Czernin J, Ilhan H, Saad F, Small EJ, Smith MR, Perez PM, Hope TA, Rauscher I, Londhe A, Lopez-Gitlitz A, Cheng S, Maurer T, Herrmann K, Eiber M, Hadaschik B. PMID: 31511295.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    42. EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2019 Nov; 46(12):2536-2544. Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K. PMID: 31440799.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    43. Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy. Mol Pharm. 2019 09 03; 16(9):3831-3841. Wang S, Blaha C, Santos R, Huynh T, Hayes TR, Beckford-Vera DR, Blecha JE, Hong AS, Fogarty M, Hope TA, Raleigh DR, Wilson DM, Evans MJ, VanBrocklin HF, Ozawa T, Flavell RR. PMID: 31381351.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    44. Hormone receptor expression of colorectal cancer diagnosed during the peri-partum period. Endocr Connect. 2019 Aug; 8(8):1149-1158. Silverstein J, Kidder W, Fisher S, Hope TA, Maisel S, Ng D, Van Ziffle J, Atreya CE, Van Loon K. PMID: 31370007.
      View in: PubMed   Mentions:
    45. Correlation of DOTATOC Uptake and Pathologic Grade in Neuroendocrine Tumors. Pancreas. 2019 08; 48(7):948-952. Chan H, Moseley C, Zhang L, Bergsland EK, Pampaloni MH, Van Loon K, Hope TA. PMID: 31268975.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Lancet Oncol. 2019 09; 20(9):1286-1294. Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J. PMID: 31375469.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    47. Can the Injected Dose Be Reduced in 68Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection? J Nucl Med. 2020 02; 61(2):189-193. Rauscher I, Fendler WP, Hope TA, Quon A, Nekolla SG, Calais J, Richter A, Haller B, Herrmann K, Weber WA, Czernin J, Eiber M. PMID: 31324710.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    48. Author Reply. Urology. 2019 07; 129:163-164. Boreta L, Gadzinski AJ, Hope TA, Feng FY. PMID: 31234998.
      View in: PubMed   Mentions:    Fields:    
    49. NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. J Nucl Med. 2019 07; 60(7):937-943. Hope TA, Abbott A, Colucci K, Bushnell DL, Gardner L, Graham WS, Lindsay S, Metz DC, Pryma DA, Stabin MG, Strosberg JR. PMID: 31263080.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncol. 2019 Jun 01; 5(6):856-863. Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J, Hope TA. PMID: 30920593.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    51. Summary of the First ISMRM-SNMMI Workshop on PET/MRI: Applications and Limitations. J Nucl Med. 2019 10; 60(10):1340-1346. Hope TA, Fayad ZA, Fowler KJ, Holley D, Iagaru A, McMillan AB, Veit-Haiback P, Witte RJ, Zaharchuk G, Catana C. PMID: 31123099.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer. AJR Am J Roentgenol. 2019 08; 213(2):266-274. Lawhn-Heath C, Flavell RR, Behr SC, Yohannan T, Greene KL, Feng F, Carroll PR, Hope TA. PMID: 31039025.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy. Urology. 2019 07; 129:165-171. Boreta L, Gadzinski AJ, Wu SY, Xu M, Greene K, Quanstrom K, Nguyen HG, Carroll PR, Hope TA, Feng FY. PMID: 30928607.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    54. Spatial gradients of healthy aging: a study of myelin-sensitive maps. Neurobiol Aging. 2019 07; 79:83-92. Karolis VR, Callaghan MF, Tseng CJ, Hope T, Weiskopf N, Rees G, Cappelletti M. PMID: 31029019.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    55. 111In-Pentetreotide Scintigraphy Versus 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden. J Nucl Med. 2019 09; 60(9):1266-1269. Hope TA, Calais J, Zhang L, Dieckmann W, Millo C. PMID: 30850506.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    56. Proceedings: Pathways for Successful Translation of New Imaging Agents and Modalities-Phase III Studies. J Nucl Med. 2019 06; 60(6):736-744. Gambhir SS, Shankar LK, Rosenthal E, Warram JM, Ghesani M, Hope TA, Jacobs PM, Jacobson GB, Wilson T, Siegel BA. PMID: 30850482.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    57. AUTHOR REPLY. Urology. 2019 03; 125:161-162. Wu SY, Feng FY, Hope TA. PMID: 30798967.
      View in: PubMed   Mentions:    Fields:    
    58. Ectopic Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma of the Nasopharynx Diagnosed by Gallium 68 DOTATATE Positron Emission Tomography/Computed Tomography. World Neurosurg. 2019 05; 125:400-404. Kim S, Dillon WP, Hope TA, El-Sayed IH, van Zante A, Wu K, Masharani U. PMID: 30797906.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    59. Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer. Eur Urol Oncol. 2019 11; 2(6):685-690. Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, Hope TA, Carroll PR, Feng FY. PMID: 31411984.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases. Clin Nucl Med. 2019 Jan; 44(1):e28-e32. Perez PM, Hope TA, Behr SC, van Zante A, Small EJ, Flavell RR. PMID: 30394930.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019 03; 125:154-162. Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. PMID: 30580002.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. WITHDRAWN: PSMA-PET: a maturing tool. Urology. 2018 Dec 20. Wu SY, Feng FY, Hope TA. PMID: 30580008.
      View in: PubMed   Mentions:    Fields:    
    63. Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology. J Nucl Med. 2019 06; 60(6):786-793. Hope TA, Goodman JZ, Allen IE, Calais J, Fendler WP, Carroll PR. PMID: 30530831.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    64. Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer. J Nucl Med. 2019 07; 60(7):910-916. Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, Greene KL, Langton-Webster B, Berkman CE, Seo Y. PMID: 30464040.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    65. Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting. Prostate. 2019 02; 79(3):244-258. Miyahira AK, Den RB, Carlo MI, de Leeuw R, Hope TA, Karzai F, McKay RR, Salami SS, Simons JW, Pienta KJ, Soule HR. PMID: 30381857.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    66. Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology. 2018 12; 289(3):730-737. Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA. PMID: 30226456.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    67. Developing an efficient phase-matched attenuation correction method for quiescent period PET in abdominal PET/MRI. Phys Med Biol. 2018 09 10; 63(18):185002. Yang J, Liu J, Wiesinger F, Menini A, Zhu X, Hope TA, Seo Y, Larson PEZ. PMID: 30106008.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by 68Ga-PSMA-11 PET/CT. Clin Genitourin Cancer. 2019 02; 17(1):e53-e55. Polverari G, Ceci F, Allen-Auerbach M, Gupta P, Fishbein MC, Reiter RE, Lee JM, Hope TA, Carroll RM, Czernin J, Calais J. PMID: 30293922.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    69. Does Extended PET Acquisition in PET/MRI Rectal Cancer Staging Improve Results? AJR Am J Roentgenol. 2018 10; 211(4):896-900. Bailey JJ, Jordan EJ, Burke C, Ohliger MA, Wang ZJ, Van Loon K, Varma MG, Hope TA. PMID: 30106609.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    70. PET/MR Imaging of the Pancreas. Magn Reson Imaging Clin N Am. 2018 Aug; 26(3):345-362. Mallak N, Hope TA, Guimaraes AR. PMID: 30376974.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Prostate cancer PET tracers: essentials for the urologist. Can J Urol. 2018 08; 25(4):9371-9383. Fraum TJ, Ludwig DR, Kim EH, Schroeder P, Hope TA, Ippolito JE. PMID: 30125515.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. PET/MRI for Gastrointestinal Imaging: Current Clinical Status and Future Prospects. Gastroenterol Clin North Am. 2018 09; 47(3):691-714. Fraum TJ, Ludwig DR, Hope TA, Fowler KJ. PMID: 30115444.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer. Eur J Nucl Med Mol Imaging. 2018 11; 45(12):2045-2054. Afshar-Oromieh A, Debus N, Uhrig M, Hope TA, Evans MJ, Holland-Letz T, Giesel FL, Kopka K, Hadaschik B, Kratochwil C, Haberkorn U. PMID: 29980832.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    74. Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma. Abdom Radiol (NY). 2018 07; 43(7):1627-1633. PMID: 29018942.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    75. Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications. AJR Am J Roentgenol. 2018 08; 211(2):286-294. Hope TA, Afshar-Oromieh A, Eiber M, Emmett L, Fendler WP, Lawhn-Heath C, Rowe SP. PMID: 29949419.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    76. Clinical Evaluation of 68Ga-PSMA-II and 68Ga-RM2 PET Images Reconstructed With an Improved Scatter Correction Algorithm. AJR Am J Roentgenol. 2018 09; 211(3):655-660. Wangerin KA, Baratto L, Khalighi MM, Hope TA, Gulaka PK, Deller TW, Iagaru AH. PMID: 29873506.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    77. Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer. Eur Urol Oncol. 2018 05; 1(1):78-82. Aggarwal R, Wei X, Kim W, Small EJ, Ryan CJ, Carroll P, Cooperberg M, Evans MJ, Hope T. PMID: 31100231.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    78. Ferumoxytol-enhanced MRI in the peripheral vasculature. Clin Radiol. 2019 01; 74(1):37-50. Lehrman ED, Plotnik AN, Hope T, Saloner D. PMID: 29731126.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    79. Variable refocusing flip angle single-shot fast spin echo imaging of liver lesions: increased speed and lesion contrast. Abdom Radiol (NY). 2018 03; 43(3):593-599. PMID: 28689221.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. Zero TE-based pseudo-CT image conversion in the head and its application in PET/MR attenuation correction and MR-guided radiation therapy planning. Magn Reson Med. 2018 10; 80(4):1440-1451. PMID: 29457287.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    81. Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction. Mol Imaging. 2018 Jan-Dec; 17:1536012118811741. Lawhn-Heath C, Flavell RR, Korenchan DE, Deller T, Lake S, Carroll PR, Hope TA. PMID: 31749411.
      View in: PubMed   Mentions:    Fields:    
    82. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma. Abdom Radiol (NY). 2018 01; 43(1):149-157. PMID: 28580538.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    83. Letter to the editor response. Abdom Radiol (NY). 2018 01; 43(1):239. PMID: 29167945.
      View in: PubMed   Mentions:    Fields:    
    84. Correction to: LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdom Radiol (NY). 2018 01; 43(1):240. Kambadakone AR, Fung A, Gupta RT, Hope TA, Fowler KJ, Lyshchik A, Ganesan K, Yaghmai V, Guimaraes AR, Sahani DV, Miller FH. PMID: 29098367.
      View in: PubMed   Mentions:    Fields:    
    85. LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdom Radiol (NY). 2018 01; 43(1):56-74. Kambadakone AR, Fung A, Gupta RT, Hope TA, Fowler KJ, Lyshchik A, Ganesan K, Yaghmai V, Guimaraes AR, Sahani DV, Miller FH. PMID: 28940042.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    86. Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT. J Nucl Med. 2018 03; 59(3):469-478. Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M, Hope T, Reiter R, Maurer T, Weber WA, Fendler WP. PMID: 29123012.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    87. Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI. J Nucl Med. 2018 05; 59(5):852-858. PMID: 29084824.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    88. Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors. J Nucl Med. 2018 01; 59(1):66-74. PMID: 29025982.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    89. Motion robust high resolution 3D free-breathing pulmonary MRI using dynamic 3D image self-navigator. Magn Reson Med. 2018 06; 79(6):2954-2967. Jiang W, Ong F, Johnson KM, Nagle SK, Hope TA, Lustig M, Larson PEZ. PMID: 29023975.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    90. Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer. EJNMMI Res. 2017 Sep 19; 7(1):77. PMID: 28929350.
      View in: PubMed   Mentions:
    91. The Role of PET/MR Imaging in Precision Medicine. PET Clin. 2017 Oct; 12(4):489-501. Huo E, Wilson DM, Eisenmenger L, Hope TA. PMID: 28867118.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    92. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017 Jun; 44(6):1014-1024. PMID: 28283702.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansPHPublic Health
    93. PET/MR Imaging in Gynecologic Oncology. Magn Reson Imaging Clin N Am. 2017 Aug; 25(3):667-684. PMID: 28668166.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    94. Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer. J Nucl Med. 2017 12; 58(12):1956-1961. Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg MR, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR. PMID: 28522741.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    95. Evaluation of Sinus/Edge-Corrected Zero-Echo-Time-Based Attenuation Correction in Brain PET/MRI. J Nucl Med. 2017 11; 58(11):1873-1879. Yang J, Wiesinger F, Kaushik S, Shanbhag D, Hope TA, Larson PEZ, Seo Y. PMID: 28473594.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    96. Change in Liver Imaging Reporting and Data System Characterization of Focal Liver Lesions Using Gadoxetate Disodium Magnetic Resonance Imaging Compared With Contrast-Enhanced Computed Tomography. J Comput Assist Tomogr. 2017 May/Jun; 41(3):376-381. PMID: 27801693.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    97. 68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study. J Nucl Med. 2017 10; 58(10):1617-1623. PMID: 28408531.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    98. Technical Note: Fast respiratory motion estimation using sorted singles without unlist processing: A feasibility study. Med Phys. 2017 May; 44(5):1632-1637. PMID: 28099995.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    99. Incidental Detection of Head and Neck Squamous Cell Carcinoma on 68Ga-PSMA-11 PET/CT. Clin Nucl Med. 2017 Apr; 42(4):e218-e220. PMID: 28166149.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    100. PET/MRI: Where might it replace PET/CT? J Magn Reson Imaging. 2017 11; 46(5):1247-1262. PMID: 28370695.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    101. Multiple arterial phase MRI of arterial hypervascular hepatic lesions: improved arterial phase capture and lesion enhancement. Abdom Radiol (NY). 2017 03; 42(3):870-876. PMID: 27770162.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    102. Hybrid ZTE/Dixon MR-based attenuation correction for quantitative uptake estimation of pelvic lesions in PET/MRI. Med Phys. 2017 Mar; 44(3):902-913. PMID: 28112410.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    103. Quantitative Evaluation of Atlas-based Attenuation Correction for Brain PET in an Integrated Time-of-Flight PET/MR Imaging System. Radiology. 2017 07; 284(1):169-179. PMID: 28234560.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    104. 18F Fluorocholine PET/MR Imaging in Patients with Primary Hyperparathyroidism and Inconclusive Conventional Imaging: A Prospective Pilot Study. Radiology. 2017 08; 284(2):460-467. PMID: 28121522.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    105. Diagnostic performance of computed tomography for parathyroid adenoma localization; a systematic review and meta-analysis. Eur J Radiol. 2017 Mar; 88:117-128. PMID: 28189196.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    106. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Abdom Radiol (NY). 2016 11; 41(11):2161-2168. PMID: 27484789.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    107. SNMMI Comment on the 2016 Society of Surgical Oncology "Choosing Wisely" Recommendation on the Use of PET/CT in Colorectal Cancer. J Nucl Med. 2017 01; 58(1):11-12. PMID: 27688471.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    108. 68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience. J Nucl Med. 2017 Jan; 58(1):81-84. PMID: 27660139.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    109. Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent. Abdom Radiol (NY). 2016 08; 41(8):1522-31. PMID: 26971341.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    110. Targeted PET imaging for prostate-specific membrane antigen in prostate cancer. Future Oncol. 2016 Nov; 12(21):2393-2396. PMID: 27453303.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    111. Performance of magnetic resonance imaging in the evaluation of first-time and reoperative primary hyperparathyroidism. Surgery. 2016 09; 160(3):747-54. PMID: 27318765.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    112. Radiation dosimetry of (68)Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing. Eur J Nucl Med Mol Imaging. 2016 Aug; 43(9):1611-20. PMID: 27260521.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    113. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol (NY). 2016 05; 41(5):963-9. PMID: 27193793.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    114. Comparison of diffusion-weighted imaging and T2-weighted single shot fast spin-echo: Implications for LI-RADS characterization of hepatocellular carcinoma. Magn Reson Imaging. 2016 Sep; 34(7):915-21. PMID: 27108359.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    115. Transient washout of hepatic hemangiomas: Potential pitfall mimicking malignancy. Radiol Case Rep. 2016 Jun; 11(2):62-6. PMID: 27257451.
      View in: PubMed   Mentions:
    116. Safety and technique of ferumoxytol administration for MRI. Magn Reson Med. 2016 May; 75(5):2107-11. PMID: 26890830.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    117. Correcting for respiratory motion in liver PET/MRI: preliminary evaluation of the utility of bellows and navigated hepatobiliary phase imaging. EJNMMI Phys. 2015 Dec; 2(1):21. PMID: 26501822.
      View in: PubMed   Mentions:
    118. Combined parenchymal and vascular imaging: High spatiotemporal resolution arterial evaluation of hepatocellular carcinoma. J Magn Reson Imaging. 2016 Apr; 43(4):859-65. PMID: 26340309.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    119. Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor. Abdom Imaging. 2015 Aug; 40(6):1432-40. PMID: 25820755.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    120. Detection of Small Pulmonary Nodules with Ultrashort Echo Time Sequences in Oncology Patients by Using a PET/MR System. Radiology. 2016 Jan; 278(1):239-46. PMID: 26133050.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    121. Vascular Imaging With Ferumoxytol as a Contrast Agent. AJR Am J Roentgenol. 2015 Sep; 205(3):W366-73. PMID: 26102308.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    122. Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses. AJR Am J Roentgenol. 2015 Jun; 204(6):1220-7. PMID: 26001231.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    123. Somatostatin imaging of neuroendocrine-differentiated prostate cancer. Clin Nucl Med. 2015 Jun; 40(6):540-1. PMID: 25783510.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    124. Greater asymmetric wall shear stress in Sievers' type 1/LR compared with 0/LAT bicuspid aortic valves after valve-sparing aortic root replacement. J Thorac Cardiovasc Surg. 2015 Jul; 150(1):59-68. PMID: 25956338.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    125. Hepatobiliary agents and their role in LI-RADS. Abdom Imaging. 2015 Mar; 40(3):613-25. PMID: 25287679.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    126. Neuroendocrine tumors: beyond the abdomen. J Comput Assist Tomogr. 2014 Nov-Dec; 38(6):898-914. PMID: 25162290.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    127. MR imaging of diffuse liver disease: from technique to diagnosis. Radiol Clin North Am. 2014 Jul; 52(4):709-24. PMID: 24889168.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    128. Functional and molecular imaging techniques in aortic aneurysm disease. Curr Opin Cardiol. 2013 Nov; 28(6):609-18. PMID: 24030165.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    129. Evaluation of Marfan patients status post valve-sparing aortic root replacement with 4D flow. Magn Reson Imaging. 2013 Nov; 31(9):1479-84. PMID: 23706513.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    130. Improvement of gadoxetate arterial phase capture with a high spatio-temporal resolution multiphase three-dimensional SPGR-Dixon sequence. J Magn Reson Imaging. 2013 Oct; 38(4):938-45. PMID: 23371926.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    131. Intravenous vasopressin for the prevention of nontarget gastrointestinal embolization during liver-directed cancer treatment: experimental study in a porcine model. J Vasc Interv Radiol. 2012 Nov; 23(11):1505-12. PMID: 22974656.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    132. Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model. Magn Reson Imaging. 2013 Jan; 31(1):139-44. PMID: 22898683.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    133. Gadolinium accumulation and fibrosis in the liver after administration of gadoxetate disodium in a rat model of active hepatic fibrosis. Radiology. 2012 Aug; 264(2):423-7. PMID: 22570507.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    134. Improved risk assessment for abdominal aortic aneurysm rupture: off-the-wall imaging. J Am Coll Cardiol. 2011 Dec 06; 58(24):2531-2. PMID: 22133854.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    135. 4D flow CMR in assessment of valve-related ascending aortic disease. JACC Cardiovasc Imaging. 2011 Jul; 4(7):781-7. PMID: 21757170.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    136. Impaired social recognition memory in recombination activating gene 1-deficient mice. Brain Res. 2011 Apr 06; 1383:187-95. McGowan PO, Hope TA, Meck WH, Kelsoe G, Williams CL. PMID: 21354115.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    137. Four-dimensional flow magnetic resonance imaging with wall shear stress analysis before and after repair of aortopulmonary fistula. Circ Cardiovasc Imaging. 2010 Nov; 3(6):766-8. Hope MD, Hope TA, Urbania TH, Higgins CB. PMID: 21081744.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    138. Bicuspid aortic valve: four-dimensional MR evaluation of ascending aortic systolic flow patterns. Radiology. 2010 Apr; 255(1):53-61. Hope MD, Hope TA, Meadows AK, Ordovas KG, Urbania TH, Alley MT, Higgins CB. PMID: 20308444.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    139. Clinical evaluation of aortic coarctation with 4D flow MR imaging. J Magn Reson Imaging. 2010 Mar; 31(3):711-8. Hope MD, Meadows AK, Hope TA, Ordovas KG, Saloner D, Reddy GP, Alley MT, Higgins CB. PMID: 20187217.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    140. Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron. Radiology. 2009 Nov; 253(2):390-8. Hope TA, High WA, Leboit PE, Chaopathomkul B, Rogut VS, Herfkens RJ, Brasch RC. PMID: 19789237.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    141. Hemodynamics in Normal Cerebral Arteries: Qualitative Comparison of 4D Phase-Contrast Magnetic Resonance and Image-Based Computational Fluid Dynamics. J Eng Math. 2009 Aug 01; 64(4):367-378. Cebral JR, Putman CM, Alley MT, Hope T, Bammer R, Calamante F. PMID: 19684874.
      View in: PubMed   Mentions:
    142. Evaluation of intracranial stenoses and aneurysms with accelerated 4D flow. Magn Reson Imaging. 2010 Jan; 28(1):41-6. Hope TA, Hope MD, Purcell DD, von Morze C, Vigneron DB, Alley MT, Dillon WP. PMID: 19577400.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    143. Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine. Invest Radiol. 2009 Mar; 44(3):135-9. Hope TA, Herfkens RJ, Denianke KS, LeBoit PE, Hung YY, Weil E. PMID: 19151610.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    144. Initial experience characterizing a type I endoleak from velocity profiles using time-resolved three-dimensional phase-contrast MRI. J Vasc Surg. 2009 Jun; 49(6):1580-4. Hope TA, Zarins CK, Herfkens RJ. PMID: 19223146.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    145. Complete intracranial arterial and venous blood flow evaluation with 4D flow MR imaging. AJNR Am J Neuroradiol. 2009 Feb; 30(2):362-6. Hope MD, Purcell DD, Hope TA, von Morze C, Vigneron DB, Alley MT, Dillon WP. PMID: 18653687.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    146. Images in cardiovascular medicine. Evaluation of bicuspid aortic valve and aortic coarctation with 4D flow magnetic resonance imaging. Circulation. 2008 May 27; 117(21):2818-9. Hope MD, Meadows AK, Hope TA, Ordovas KG, Reddy GP, Alley MT, Higgins CB. PMID: 18506021.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    147. Imaging of the thoracic aorta with time-resolved three-dimensional phase-contrast MRI: a review. Semin Thorac Cardiovasc Surg. 2008; 20(4):358-64. Hope TA, Herfkens RJ. PMID: 19251177.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    148. Comparison of flow patterns in ascending aortic aneurysms and volunteers using four-dimensional magnetic resonance velocity mapping. J Magn Reson Imaging. 2007 Dec; 26(6):1471-9. Hope TA, Markl M, Wigström L, Alley MT, Miller DC, Herfkens RJ. PMID: 17968892.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    149. Time-resolved 3D quantitative flow MRI of the major intracranial vessels: initial experience and comparative evaluation at 1.5T and 3.0T in combination with parallel imaging. Magn Reson Med. 2007 Jan; 57(1):127-40. Bammer R, Hope TA, Aksoy M, Alley MT. PMID: 17195166.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    Thomas's Networks
    Concepts (395)
    Derived automatically from this person's publications.
    _
    Co-Authors (115)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _